¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reticular lymphocyte"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • annular reticular fiber
    °í¸®±×¹°¼¶À¯
  • intralaminar reticular nucleus
    ¼¶À¯ÆÇ¼Ó±×¹°ÇÙ, ÆÇ³»¸Á»óÇÙ
  • pontine tegmental reticular nucleus
    ´Ù¸®³úµÚÆÇ±×¹°ÇÙ, ±³³úÇǰ³¸Á»óÇÙ
  • paramedian reticular nucleus
    Á¤Áß°ç±×¹°ÇÙ, Á¤Áß°ç¸Á»óÇÙ
  • reticular
    ±×¹°-, ¸Á»ó-
  • reticular acropigmentation
    ±×¹°¸»´Ü»ö¼ÒÄ§Âø
  • reticular atrophy
    ±×¹°À§Ãà, ¸Á»óÀ§Ãà
  • reticular cell
    ±×¹°¼¼Æ÷, ¸Á»ó¼¼Æ÷
  • reticular degeneration
    ±×¹°º¯¼º, ¸Á»óº¯¼º
  • reticular dermis
    ±×¹°ÁøÇÇ, ¸Á»óÁøÇÇ
  • reticular fiber
    ±×¹°¼¶À¯, ¸Á»ó¼¶À¯
  • reticular formation
    ±×¹°Ã¼, ¸Á»óü
  • reticular inhibitory area
    ±×¹°Ã¼¾ïÁ¦ºÎÀ§
  • reticular keratitis
    ±×¹°°¢¸·¿°
  • reticular lamina
    ±×¹°ÆÇ, ¸Á»óÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • monocyte lymphocyte ratio
    ´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    °¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
  • annular reticular fiber
    µ¹¸²¼¼¸Á¼¶À¯
  • reticular acropigmentation
    ±×¹°¸»´Ü»ö¼ÒÄ§Âø
  • reticular anastomosis
    ±×¹°¿¬°á, ¸Á»ó¿¬°á
  • reticular atrophy
    ¸Á»óÀ§Ãà
  • reticular inhibitory area
    ±×¹°Ã¼¾ïÁ¦ºÎÀ§
  • reticular cell
    ±×¹°¼¼Æ÷
  • reticular degeneration
    ±×¹°º¯¼º
  • reticular density
    ¸Á»óÀ½¿µ, ±×¹°À½¿µ
  • reticular dermis
    ¸Á»óÁøÇÇ
  • reticular fiber
    ±×¹°¼¶À¯, ¸Á»ó¼¶À¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • T lymphocyte
    T ¸²ÇÁ±¸
  • T-lymphocyte
    T-Àӯı¸
  • anti-lymphocyte globulin
    ¸²ÇÁ±¸ Çױ۷κҸ°
  • antigen, lymphocyte defined (LD)
    ¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
  • granulocyte-monocyte-lymphocyte antigens
    °ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • hodgkins disease,lymphocyte predominance
    ¸²ÇÁ±¸ ÇöÀúÇü
  • primed lymphocyte
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lymphocyte
    ¸²ÇÁ±¸
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • lymphocyte activating factor (LAF)
    ¸²ÇÁ±¸ Ȱ¼ºÈ­ÀÎÀÚ
  • lymphocyte analysis
    ¸²ÇÁ±¸ºÐ¼®
  • lymphocyte culture, mixed
    È¥ÇÕ ¸²ÇÁ±¸¹è¾ç
  • lymphocyte defined antigen
    ¸²ÇÁ±¸±ÔÁ¤Ç׿ø.
  • lymphocyte development
    ¸²ÇÁ±¸¹ßÀ°
  • lymphocyte dysfunction
    ¸²ÇÁ±¸±â´ÉÀå¾Ö<--ºÎÀü>
  • lymphocyte inhibitory factor (LIF)
    ¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
  • lymphocyte interaction
    ¸²ÇÁ±¸»óÈ£ÀÛ¿ë.
  • lymphocyte microcytotoxicity assay
    ¸²ÇÁ±¸¼Ò¼¼Æ÷µ¶¼º°Ë»ç
  • lymphocyte production
    ¸²ÇÁ±¸»ý¼º
  • lymphocyte proliferation
    ¸²ÇÁ±¸Áõ½Ä
  • lymphocyte transformation
    ¸²ÇÁ±¸Àüȯ(¡­Ï¹ ï®üµ).
  • lymphocyte, resident
    »óÁÖ¸²ÇÁ±¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á